COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 79 filers reported holding COHERUS BIOSCIENCES INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,090 | -12.4% | 3,500 | 0.0% | 0.00% | – |
Q2 2023 | $14,945 | -37.6% | 3,500 | 0.0% | 0.00% | – |
Q1 2023 | $23,940 | -13.6% | 3,500 | 0.0% | 0.00% | – |
Q4 2022 | $27,720 | -16.0% | 3,500 | 0.0% | 0.00% | – |
Q3 2022 | $33,000 | +32.0% | 3,500 | 0.0% | 0.00% | – |
Q2 2022 | $25,000 | -44.4% | 3,500 | 0.0% | 0.00% | – |
Q1 2022 | $45,000 | -18.2% | 3,500 | 0.0% | 0.00% | – |
Q4 2021 | $55,000 | -1.8% | 3,500 | 0.0% | 0.00% | – |
Q3 2021 | $56,000 | +16.7% | 3,500 | 0.0% | 0.00% | – |
Q2 2021 | $48,000 | -5.9% | 3,500 | 0.0% | 0.00% | – |
Q1 2021 | $51,000 | -15.0% | 3,500 | 0.0% | 0.00% | – |
Q4 2020 | $60,000 | -6.2% | 3,500 | 0.0% | 0.00% | – |
Q3 2020 | $64,000 | +3.2% | 3,500 | 0.0% | 0.00% | – |
Q2 2020 | $62,000 | +10.7% | 3,500 | 0.0% | 0.00% | – |
Q1 2020 | $56,000 | -11.1% | 3,500 | 0.0% | 0.00% | – |
Q4 2019 | $63,000 | -10.0% | 3,500 | 0.0% | 0.00% | – |
Q3 2019 | $70,000 | -30.0% | 3,500 | -30.0% | 0.00% | -100.0% |
Q3 2015 | $100,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 200,000 | $1,448,000 | 1.54% |
Tri Locum Partners LP | 376,486 | $2,726,000 | 1.12% |
Perceptive Advisors | 3,645,471 | $26,393,000 | 0.83% |
TANG CAPITAL MANAGEMENT LLC | 750,000 | $5,430,000 | 0.82% |
Bridge City Capital, LLC | 162,146 | $1,174,000 | 0.62% |
Knott David M Jr | 186,134 | $1,348,000 | 0.57% |
Aristotle Capital Boston, LLC | 2,322,168 | $16,812,000 | 0.50% |
Phocas Financial Corp. | 316,455 | $2,291,000 | 0.34% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $22,644,000 | 0.30% |
Temasek Holdings (Private) Ltd | 7,381,116 | $53,439,280 | 0.29% |